American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead: Human brain effects of DMT assessed via EEG-fMRI

Lead: Human brain effects of DMT assessed via EEG-fMRI

Tuesday 28th March 2023

Discover how DMT impacts brain function and explore new addiction treatments in this episode of 'This Week in Addiction Medicine' from ASAM.
6 minutes
Informative
Engaging
Educational
Thought-provoking
Raw

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

How DMT Impacts the Brain: Insights from EEG-fMRI Studies

The study found a dysregulating effect on activity in the transmodal association pole (TOP), which may be evidence of increased information processing and hyperassociative cognition.
Ever wondered how psychedelics like DMT affect your brain? This episode of 'This Week in Addiction Medicine' from ASAM dives into the fascinating world of N,N-Dimethyltryptamine (DMT) and its potential as a treatment for depression. Using advanced techniques like electroencephalography (EEG) and functional MRI (fMRI), researchers have uncovered some intriguing findings. They discovered that DMT causes a dysregulation in the transmodal association pole (TOP), an area rich in serotonin 2A receptors.
This dysregulation leads to increased communication between the TOP and other brain regions, potentially enhancing information processing and hyperassociative cognition. Imagine your brain working in overdrive, making connections faster than ever before. This episode doesn't just stop at psychedelics. It also explores a prospective study on patients with co-occurring psychiatric disorders receiving inpatient treatment for substance use disorder. Public attitudes towards opioid use and the link between social impairment and substance use are also discussed.
Additionally, you'll hear about a randomized clinical trial from China where personalized text messages based on behavior change theory doubled the quit rate for smokers compared to non-personalized messages. Finally, the episode delves into the potential of prescription psychostimulants as a treatment for cocaine use disorder. While the data is still emerging, there's hope that these stimulants could improve patient retention and outcomes when used as part of a comprehensive treatment plan.
Whether you're a healthcare professional, a student, or someone affected by addiction, this episode offers valuable insights into the latest research and treatments in addiction medicine.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.